Keybanc Maintains Overweight on 1Life Healthcare, Lowers Price Target to $38
Keybanc analyst Donald Hooker maintains 1Life Healthcare (NASDAQ:ONEM) with a Overweight and lowers the price target from $41 to $38.
Recap: 1Life Healthcare Q2 Earnings
Shares of 1Life Healthcare (NASDAQ:ONEM) rose in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 25.00% over the past year to ($0.30), which missed the estimate of ($0.20).
1Life Healthcare Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $120.42M Beat $115.67M Estimate
1Life Healthcare (NASDAQ:ONEM) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.20) by 50 percent. This is a 25 percent decrease over losses of $(0.24) per share from the
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
Monday morning, 285 companies reached new 52-week lows.
Canaccord Genuity Maintains Buy on 1Life Healthcare, Lowers Price Target to $48
Canaccord Genuity analyst Richard Close maintains 1Life Healthcare (NASDAQ:ONEM) with a Buy and lowers the price target from $56 to $48.
Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first operating loss as a listed company, as a record regulatory fine it was
Earnings Scheduled For May 12, 2021
Companies Reporting Before The Bell
• PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.